|
⚲
|
| Logos Global Management LP
✚
|
|
|---|---|
| CRD # | 305162 |
| SEC # | 801-117248 |
| CIK # | 0001792126 |
| AUM | $1.4 B (2025-04-30) |
| Employees | 11 (55% Investors, 0% Brokers) |
| Phone | 415-801-4660 |
| Address | 1 Letterman Drive San Francisco, CA 94129 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| VC | Logos Opportunities Fund IV LP | [2024-03-29] | 284.0 | 182.9 |
| VC | Logos Opportunities Fund III LP | [2022-03-31] | 208.1 | 156.0 |
| VC | Logos SPV 1 LP | [2022-03-31] | 0.0 | 0.0 |
| VC | Logos Opportunities Fund II LP | [2021-03-31] | 44.0 | 63.1 |
| VC | Logos Opportunities Fund I LP | [2019-12-23] | 44.0 | 0.0 |
| HF | Logos Global Master Fund LP | [2019-07-26] | 219.3 | 913.4 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 6 | 1,435.5 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 6 | 1,435.5 |
| By Discretionary | ||
| Discretionary | 6 | 1,435.5 |
| Non-Discretionary | 0 | 0.0 |
| Total | 6 | 1,435.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 913.4 | |
| United States Persons | 522.1 | |
| Total | 6 | 1,435.5 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Virginia Yee | 7 | ||
| Graham Walmsley | 9 | ||
| Arsani William | 9 | ||
| Edward Zhong | 6 | ||
| Edward Callaway | 4 | ||
| Yanni Souroutzidis | 4 | ||
| Derek Gould | 3 | ||
| Logos GP LLC | 3 | ||
| Logos Opportunities II GP LLC | 2 | ||
| Logos Opportunities IV GP LLC | 1 | ||
| Logos Opportunties GP LLC | 1 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001792126] | |
| 3 | [0001792126] | |
| 4 | [0001792126] | |
| SC 13D | [0001792126] | |
| SC 13G | [0001792126] |
| Form 3/4/5 Subject | 2011 - 2025 |
|---|---|
| Verve Therapeutics, Inc. | |
| Logos Global Management LP | |
| Eledon Pharmaceuticals, Inc. | |
| Dyne Therapeutics, Inc. |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Irenic Capital Management LP
✚
|
NY | 1.5 |
|
DSC Meridian Capital LP
✚
|
NY | 1.4 |
|
Zweig-Dimenna Associates LLC
✚
|
NY | 1.4 |
|
Voss Capital LP
✚
|
TX | 1.4 |
|
EAM Global Investors LLC
✚
|
CA | 1.4 |
|
Water Island Capital LLC
✚
|
NY | 1.4 |
|
Squadra Investments - Gestao de Recursos LTDA
✚
|
1.4 | |
|
Passaic Partners LLC
✚
|
NJ | 1.4 |
|
Boldhaven Management LLP
✚
|
1.4 | |
|
Needham Investment Management LLC
✚
|
NY | 1.4 |